JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
VBOC
4851
DELISTED
Viscogliosi Brothers Acquisition Corp Common Stock
VBOC
| $198K | ﹤0.01% |
+19,954
| New | +$197K |
2022 Q2
0 quarters
|
|
4852
Future Fuel
FF
$220M
| $197K | ﹤0.01% |
27,157
-345,466
| -93% | -$2.9M |
2013 Q2
36 quarters
|
|
4853
Mirum Pharmaceuticals
MIRM
$5.45B
| $197K | ﹤0.01% |
10,135
+4,816
| +91% | +$114K |
2019 Q3
11 quarters
|
|
4854
PUT
Airbnb
ABNB
$94.6B
| $196K | ﹤0.01% |
2,200
-890,500
| -100% | -$116M |
2020 Q4
6 quarters
|
|
4855
WisdomTree US AI Enhanced Value Fund
AIVL
$406M
| $196K | ﹤0.01% |
2,206
+126
| +6% | +$11.9K |
2014 Q4
30 quarters
|
|
4856
Citizens & Northern Corp
CZNC
$452M
| $196K | ﹤0.01% |
8,119
-2,798
| -26% | -$67.7K |
2013 Q2
36 quarters
|
|
|
KC
4857
Kingsoft Cloud Holdings
KC
$2.73B
| $196K | ﹤0.01% |
44,062
-304,520
| -87% | -$1.3M |
2020 Q2
8 quarters
|
|
4858
OneWater Marine
ONEW
$161M
| $196K | ﹤0.01% |
5,920
+780
| +15% | +$26K |
2020 Q1
9 quarters
|
|
|
TCDA
4859
DELISTED
Tricida, Inc. Common Stock
TCDA
| $196K | ﹤0.01% |
20,329
-22,558
| -53% | -$215K |
2018 Q2
16 quarters
|
|
|
OGI
4860
Organigram Holdings
OGI
$142M
| $195K | ﹤0.01% |
+5,845
| New | +$29.8K |
2022 Q2
0 quarters
|
|
|
STSA
4861
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $195K | ﹤0.01% |
+46,998
| New | +$166K |
2022 Q2
0 quarters
|
|
|
CNCE
4862
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $195K | ﹤0.01% |
46,349
+46,307
| +110,255% | +$183K |
2017 Q4
18 quarters
|
|
4863
Babcock & Wilcox
BW
$863M
| $194K | ﹤0.01% |
32,113
+6,079
| +23% | +$42.6K |
2020 Q2
8 quarters
|
|
4864
iShares Dow Jones US ETF
IYY
$3.03B
| $194K | ﹤0.01% |
2,098
-157
| -7% | -$15.8K |
2013 Q2
36 quarters
|
|
4865
CALL
Sportradar
SRAD
$3.51B
| $194K | ﹤0.01% |
+24,600
| New | +$269K |
2022 Q2
0 quarters
|
|
4866
Alerus Financial
ALRS
$791M
| $193K | ﹤0.01% |
8,104
-5,652
| -41% | -$143K |
2019 Q4
10 quarters
|
|
|
CLSC
4867
DELISTED
Cabana Target Leading Sector Conservative ETF
CLSC
| $193K | ﹤0.01% |
+9,127
| New | +$197K |
2022 Q2
0 quarters
|
|
|
CTO
4868
CTO Realty Growth
CTO
$763M
| $192K | ﹤0.01% |
9,441
+195
| +2% | +$4.1K |
2017 Q4
18 quarters
|
|
4869
Invesco DB Base Metals Fund
DBB
$361M
| $190K | ﹤0.01% |
9,759
-3,627
| -27% | -$84.2K |
2020 Q4
6 quarters
|
|
4870
Rush Enterprises Class B
RUSHB
$6.34B
| $190K | ﹤0.01% |
8,606
+56
| +0.7% | +$1.21K |
2017 Q4
18 quarters
|
|
4871
Veritone
VERI
$76.2M
| $190K | ﹤0.01% |
29,105
-1,244
| -4% | -$12.5K |
2020 Q2
8 quarters
|
|
4872
Fidelity MSCI Industrials Index ETF
FIDU
$2.19B
| $188K | ﹤0.01% |
+4,169
| New | +$204K |
2022 Q2
0 quarters
|
|
|
NEUE
4873
DELISTED
NeueHealth
NEUE
| $188K | ﹤0.01% |
1,290
-227
| -15% | -$33K |
2021 Q3
3 quarters
|
|
4874
Aptus Collared Investment Opportunity ETF
ACIO
$2.39B
| $187K | ﹤0.01% |
+6,487
| New | +$194K |
2022 Q2
0 quarters
|
|
4875
C4 Therapeutics
CCCC
$386M
| $187K | ﹤0.01% |
24,782
-44,638
| -64% | -$393K |
2020 Q4
6 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.